PetIQ Inc (NASDAQ:PETQ) was the recipient of some unusual options trading activity on Tuesday. Traders purchased 682 put options on the company. This represents an increase of 1,118% compared to the average daily volume of 56 put options.
A number of equities analysts have recently commented on PETQ shares. Zacks Investment Research raised shares of PetIQ from a “hold” rating to a “buy” rating and set a $36.00 price target on the stock in a research report on Friday, August 9th. BidaskClub lowered shares of PetIQ from a “hold” rating to a “sell” rating in a research report on Saturday, September 7th. Guggenheim started coverage on shares of PetIQ in a research report on Thursday, May 23rd. They issued a “buy” rating and a $35.00 price target on the stock. Finally, ValuEngine lowered shares of PetIQ from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. One investment analyst has rated the stock with a sell rating, one has given a hold rating and six have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $41.33.
Shares of PETQ stock opened at $26.21 on Thursday. PetIQ has a 1 year low of $21.29 and a 1 year high of $42.75. The firm’s fifty day simple moving average is $30.94 and its 200 day simple moving average is $30.54. The firm has a market capitalization of $750.99 million, a P/E ratio of 20.97, a price-to-earnings-growth ratio of 0.99 and a beta of 2.09. The company has a current ratio of 2.97, a quick ratio of 1.66 and a debt-to-equity ratio of 0.33.
In other PetIQ news, insider Will Santana sold 10,000 shares of PetIQ stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $32.34, for a total value of $323,400.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders sold 80,000 shares of company stock valued at $2,639,000 over the last quarter. Corporate insiders own 23.79% of the company’s stock.
A number of institutional investors and hedge funds have recently bought and sold shares of the business. AQR Capital Management LLC boosted its stake in PetIQ by 4.0% during the second quarter. AQR Capital Management LLC now owns 9,620 shares of the company’s stock worth $317,000 after buying an additional 367 shares in the last quarter. Manchester Capital Management LLC acquired a new stake in PetIQ during the first quarter worth $30,000. Zions Bancorporation N.A. boosted its stake in PetIQ by 14.2% during the second quarter. Zions Bancorporation N.A. now owns 7,700 shares of the company’s stock worth $254,000 after buying an additional 955 shares in the last quarter. GSA Capital Partners LLP boosted its stake in PetIQ by 12.2% during the second quarter. GSA Capital Partners LLP now owns 9,089 shares of the company’s stock worth $300,000 after buying an additional 989 shares in the last quarter. Finally, Boston Partners boosted its stake in PetIQ by 1.3% during the second quarter. Boston Partners now owns 100,206 shares of the company’s stock worth $3,302,000 after buying an additional 1,266 shares in the last quarter. Hedge funds and other institutional investors own 91.72% of the company’s stock.
PetIQ, Inc operates as a pet health and wellness company. It operates through two segments, Products and Services. It manufactures and distributes veterinarian services and veterinarian-grade pet products, including prescription (Rx) medications, over-the-counter (OTC) flea and tick preventatives, and health and wellness products for dogs and cats.
Recommended Story: Stop Order
Receive News & Ratings for PetIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ and related companies with MarketBeat.com's FREE daily email newsletter.